COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,429 Articles (22,835 medRxiv, 8,594 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

Analysis of signs and symptoms of SARS-CoV-2 virus infection considering different waves using Machine Learning
Ulrichsen, F. C., da Costa Sena, A., Figueiredo, K., Porto, L. C.
10.1101/2024.02.12.24302722 — Posted: 2024-02-13
Long-term cardiovascular safety of COVID-19 vaccination according to brand, dose and combinations: Cohort study of 46 million adults in England
Ip, S. H. Y., North, T.-L., Torabi, F., Li, Y., Abbasizanjani, H., Akbari, A., Horne, E. M. F., Denholm, R., Keene, S., Denaxas, S., Banerjee, A., Khunti, K., Sudlow, C., Whiteley, W., Sterne, J. A. C., Wood, A., Walker, V.
10.1101/2024.02.12.24302698 — Posted: 2024-02-13
A Phase II Study Integrating a Single-Blind Safety Phase with a Double-Blind, Placebo-Controlled Randomized Phase, Assessing Single-Dose Intramuscular or Intranasal Administration to Evaluate the Safety and Immunogenicity of the Recombinant Vaccine Against COVID-19 (AVX/COVID-12 "Patria") Based on an Active Newcastle Disease Viral Vector as a Heterologous Booster in Subjects with Evidence of Previous Immunity to SARS-CoV-2.
Lopez-Macias, C., Torres, M., Armenta-Copca, B., Wacher, N. H., Castro-Castrezana, L., Colli-Dominguez, A. A., Rivera-Hernandez, T., Torres-Flores, A., Ramirez-Martinez, L., Paz-De la Rosa, G., Rojas-Martinez, O., Suarez-Martinez, J. A., Peralta-Sanchez, G., Carranza, C., Juarez, E., Zamudio-Meza, H., Carreto-Binaghi, L. E., Viettri, M., Romero-Rodriguez, D., Palencia, A., Reyna-Rosas, E., Marquez-Garcia, J. E., Sarfati-Mizrahi, D., Sun, W., Chagoya-Cortes, H. E., Castro-Peralta, F., Palese, P., Krammer, F., Garcia-Sastre, A., Lozano-Dubernard, B.
10.1101/2024.02.11.24302594 — Posted: 2024-02-13
Knowledge, Attitude, and Practices towards COVID-19 Infection and Prevention Measures among Medical Students
Ruyeras, J. M. M. J., Basi, P. K. V., Canete, L. A. C., Capoy, N. A. M., Castillo, M. Y. S., Colonia, C. J. T., Gantuangco, B. L. M. E., Jumamil, P. A. V., Mantilla, H. P. S., Talili, G. S. C., Untal, R. C. G.
10.1101/2024.02.12.24302741 — Posted: 2024-02-13
SARS-CoV-2 Omicron lineage XBB spike structures, conformations, antigenicity, and receptor recognition
Zhang, Q. E., Lindenberger, J., Parsons, R., Thakur, B., Parks, R., Park, C. S., Huang, X., Sammour, S., Janowska, K., Spence, T. N., Edwards, R. J., Martin, M., Williams, W. B., Gobeil, S., Montefiori, D. C., Korber, B., Saunders, K. O., Haynes, B. F., Haynes, B. F., Henderson, R., Acharya, P.
10.1101/2024.02.12.580004 — Posted: 2024-02-13
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for de novo drug design and computational chemistry approaches
Hazemann, J., Kimmerlin, T., Lange, R., Sweeney, A. M., Bourquin, G., Ritz, D., Czodrowski, P.
10.1101/2024.02.12.579977 — Posted: 2024-02-13
Infer metabolic directions and magnitudes from moment differences of mass-weighted intensity distributions
Li, T.
10.1101/2024.02.12.579906 — Posted: 2024-02-13
Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage
Shukla, N., Roelle, S. M., Snell, J. C., DelSignore, O., Bruchez, A. M., Matreyek, K.
10.1101/2024.02.13.580056 — Posted: 2024-02-13
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19
Boon, A. C., Bricker, T. L., Fritch, E. J., Leist, S. R., Gully, K. L., Baric, R. S., Graham, R., Troan, B. V., Mahoney, M., Janetka, J. W.
10.1101/2024.02.09.579701 — Posted: 2024-02-12
FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
Baazim, H., Koyuncu, E., Tuncman, G., Burak, M. F., Merkel, L., Bahour, N., Karabulut, E., Lee, G. Y., Hanifehnezhad, A., Karagoz, Z. F., Foldes, K., Engin, I., Erman, A. G., Oztop, S., Filazi, N., Gul, B., Ceylan, A., Cinar, O. O., Can, F., Kim, H., Al-Hakeem, A., Li, H., Semerci, F., Lin, X., Yilmaz, E., Ergonul, O., Ozkul, A., Hotamisligil, G. S.
10.1101/2024.02.10.579717 — Posted: 2024-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).